165 related articles for article (PubMed ID: 36259229)
21. Cutaneous erosions: a herald for impending pancytopenia in methotrexate toxicity.
Shiver MB; Hall LA; Conner KB; Brown GE; Cheung WL; Wirges ML
Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046458
[TBL] [Abstract][Full Text] [Related]
22. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
23. Methotrexate-induced cytotoxicity and genotoxicity in germ cells of mice: intervention of folic and folinic acid.
Padmanabhan S; Tripathi DN; Vikram A; Ramarao P; Jena GB
Mutat Res; 2009 Feb; 673(1):43-52. PubMed ID: 19110071
[TBL] [Abstract][Full Text] [Related]
24. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
[TBL] [Abstract][Full Text] [Related]
25. Methotrexate Cutaneous Ulceration: A Systematic Review of Cases.
Berna R; Rosenbach M; Margolis DJ; Mitra N; Baumrin E
Am J Clin Dermatol; 2022 Jul; 23(4):449-457. PubMed ID: 35486323
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients.
Kivity S; Zafrir Y; Loebstein R; Pauzner R; Mouallem M; Mayan H
Autoimmun Rev; 2014 Nov; 13(11):1109-13. PubMed ID: 25172240
[TBL] [Abstract][Full Text] [Related]
27. Acute severe methotrexate toxicity in patients with psoriasis: a case series and discussion.
Yélamos O; Català A; Vilarrasa E; Roé E; Puig L
Dermatology; 2014; 229(4):306-9. PubMed ID: 25401478
[TBL] [Abstract][Full Text] [Related]
28. Methotrexate related cutaneous adverse drug reactions: a systematic literature review.
Zuber M; Harikrishna ; Vidhyashree ; Chhabra M; Venkataraman R; Kumar S; Rashid M
J Basic Clin Physiol Pharmacol; 2022 Sep; 33(5):549-565. PubMed ID: 34706401
[TBL] [Abstract][Full Text] [Related]
29. Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases.
Mori S; Hidaka M; Kawakita T; Hidaka T; Tsuda H; Yoshitama T; Migita K; Ueki Y
PLoS One; 2016; 11(4):e0154744. PubMed ID: 27128679
[TBL] [Abstract][Full Text] [Related]
30. [Subcutaneous methotrexate in psoriasis and psoriatic arthritis treatment].
Szczerkowska-Dobosz A
Wiad Lek; 2016; 69(4):675-679. PubMed ID: 27941209
[TBL] [Abstract][Full Text] [Related]
31. Low serum level and chronic toxicity for methotrexate. Case Report.
Musameh I; Al-Bakri F; Ezzeldin A
Qatar Med J; 2023; 2023(4):31. PubMed ID: 38026729
[TBL] [Abstract][Full Text] [Related]
32. Fatal pancytopenia in a hemodialysis patient after treatment with low-dose methotrexate.
Cheung KK; Chow KM; Szeto CC; Tai MH; Kwan BC; Li PK
J Clin Rheumatol; 2009 Jun; 15(4):177-80. PubMed ID: 19502905
[TBL] [Abstract][Full Text] [Related]
33. Shingles: More than Meets the Eye.
Komitova RT; Grklanov VA; Lindas KK; Ganeva PV
Folia Med (Plovdiv); 2019 Mar; 61(1):158-162. PubMed ID: 31237855
[TBL] [Abstract][Full Text] [Related]
34. Methotrexate toxicity in psoriasis-A multicentric retrospective study.
Singh GK; Sapra D; Bahuguna A; Das P
Dermatol Ther; 2022 Oct; 35(10):e15765. PubMed ID: 36054575
[TBL] [Abstract][Full Text] [Related]
35. Life-Threatening Gastrointestinal Mucosal Necrosis during Methotrexate Treatment for Rheumatoid Arthritis.
Tsukada T; Nakano T; Miyata T; Sasaki S
Case Rep Gastroenterol; 2013; 7(3):470-5. PubMed ID: 24348319
[TBL] [Abstract][Full Text] [Related]
36. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review.
Prey S; Paul C
Br J Dermatol; 2009 Mar; 160(3):622-8. PubMed ID: 18945303
[TBL] [Abstract][Full Text] [Related]
37. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
Prodanovich S; Ma F; Taylor JR; Pezon C; Fasihi T; Kirsner RS
J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471
[TBL] [Abstract][Full Text] [Related]
38. Complete clinical and functional recovery following low-dose methotrexate related paraparesis in a patient with compound c.1298A>C AND c.677C>T MTHFR polymorphism: A case report.
Saviola G; Abdi-Ali L; Sacco S; Comini L; Plewnia K; Rossi M; Orrico A
Medicine (Baltimore); 2018 Dec; 97(49):e13350. PubMed ID: 30544400
[TBL] [Abstract][Full Text] [Related]
39. Methotrexate efficacy and tolerance in plaque psoriasis. A prospective real-life multicentre study in France.
Tournier A; Khemis A; Maccari F; Reguiai Z; Bégon E; Fougerousse AC; Amy de la Breteque M; Beneton N; Parier J; Boyé T; Avenel-Audran M; Girard C; Pallure V; Perrot JL; Bastien M; Mahé E; Beauchet A;
Ann Dermatol Venereol; 2019 Feb; 146(2):106-114. PubMed ID: 30704943
[TBL] [Abstract][Full Text] [Related]
40. Methotrexate-induced pancytopenia: a case series of 46 patients.
Ajmani S; Preet Singh Y; Prasad S; Chowdhury A; Aggarwal A; Lawrence A; Misra R; Mishra R; Agarwal V
Int J Rheum Dis; 2017 Jul; 20(7):846-851. PubMed ID: 28261918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
